 | • レポートコード：MRC2-11QY06727 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はG-CSFバイオシミラーのグローバル市場について調査・分析したレポートです。種類別（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子）市場規模、用途別（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別G-CSFバイオシミラーの競争状況、市場シェア ・世界のG-CSFバイオシミラー市場：種類別市場規模 2015年-2020年（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子） ・世界のG-CSFバイオシミラー市場：種類別市場規模予測 2021年-2026年（ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子） ・世界のG-CSFバイオシミラー市場：用途別市場規模 2015年-2020年（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症） ・世界のG-CSFバイオシミラー市場：用途別市場規模予測 2021年-2026年（血液疾患、腫瘍学疾患、慢性・自己免疫疾患、成長ホルモン欠乏症） ・北米のG-CSFバイオシミラー市場分析：米国、カナダ ・ヨーロッパのG-CSFバイオシミラー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのG-CSFバイオシミラー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のG-CSFバイオシミラー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのG-CSFバイオシミラー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis、Roche、Merck & Co.、Sanofi、Johnson & Johnson、Gilead Science、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca、Bayer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
Market Analysis and Insights: Global G-CSF Biosimilars Market
The global G-CSF Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global G-CSF Biosimilars Scope and Market Size
G-CSF Biosimilars market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global G-CSF Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the G-CSF Biosimilars market is segmented into
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Segment by Application, the G-CSF Biosimilars market is segmented into
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Regional and Country-level Analysis
The G-CSF Biosimilars market is analysed and market size information is provided by regions (countries).
The key regions covered in the G-CSF Biosimilars market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and G-CSF Biosimilars Market Share Analysis
G-CSF Biosimilars market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in G-CSF Biosimilars business, the date to enter into the G-CSF Biosimilars market, G-CSF Biosimilars product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
1 Study Coverage
1.1 G-CSF Biosimilars Product Introduction
1.2 Market Segments
1.3 Key G-CSF Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global G-CSF Biosimilars Market Size Growth Rate by Type
1.4.2 Human Growth Hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal Antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.5 Market by Application
1.5.1 Global G-CSF Biosimilars Market Size Growth Rate by Application
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.5.4 Chronic And Autoimmune Diseases
1.5.5 Growth Hormone Deficiencies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global G-CSF Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global G-CSF Biosimilars Revenue 2015-2026
2.1.2 Global G-CSF Biosimilars Sales 2015-2026
2.2 Global G-CSF Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global G-CSF Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global G-CSF Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global G-CSF Biosimilars Competitor Landscape by Players
3.1 G-CSF Biosimilars Sales by Manufacturers
3.1.1 G-CSF Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 G-CSF Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 G-CSF Biosimilars Revenue by Manufacturers
3.2.1 G-CSF Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by G-CSF Biosimilars Revenue in 2019
3.2.5 Global G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 G-CSF Biosimilars Price by Manufacturers
3.4 G-CSF Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers G-CSF Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into G-CSF Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global G-CSF Biosimilars Market Size by Type (2015-2020)
4.1.1 Global G-CSF Biosimilars Sales by Type (2015-2020)
4.1.2 Global G-CSF Biosimilars Revenue by Type (2015-2020)
4.1.3 G-CSF Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global G-CSF Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global G-CSF Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global G-CSF Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 G-CSF Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global G-CSF Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global G-CSF Biosimilars Market Size by Application (2015-2020)
5.1.1 Global G-CSF Biosimilars Sales by Application (2015-2020)
5.1.2 Global G-CSF Biosimilars Revenue by Application (2015-2020)
5.1.3 G-CSF Biosimilars Price by Application (2015-2020)
5.2 G-CSF Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global G-CSF Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global G-CSF Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global G-CSF Biosimilars Price Forecast by Application (2021-2026)
6 North America
6.1 North America G-CSF Biosimilars by Country
6.1.1 North America G-CSF Biosimilars Sales by Country
6.1.2 North America G-CSF Biosimilars Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America G-CSF Biosimilars Market Facts & Figures by Type
6.3 North America G-CSF Biosimilars Market Facts & Figures by Application
7 Europe
7.1 Europe G-CSF Biosimilars by Country
7.1.1 Europe G-CSF Biosimilars Sales by Country
7.1.2 Europe G-CSF Biosimilars Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe G-CSF Biosimilars Market Facts & Figures by Type
7.3 Europe G-CSF Biosimilars Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific G-CSF Biosimilars by Region
8.1.1 Asia Pacific G-CSF Biosimilars Sales by Region
8.1.2 Asia Pacific G-CSF Biosimilars Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific G-CSF Biosimilars Market Facts & Figures by Type
8.3 Asia Pacific G-CSF Biosimilars Market Facts & Figures by Application
9 Latin America
9.1 Latin America G-CSF Biosimilars by Country
9.1.1 Latin America G-CSF Biosimilars Sales by Country
9.1.2 Latin America G-CSF Biosimilars Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America G-CSF Biosimilars Market Facts & Figures by Type
9.3 Central & South America G-CSF Biosimilars Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa G-CSF Biosimilars by Country
10.1.1 Middle East and Africa G-CSF Biosimilars Sales by Country
10.1.2 Middle East and Africa G-CSF Biosimilars Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa G-CSF Biosimilars Market Facts & Figures by Type
10.3 Middle East and Africa G-CSF Biosimilars Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer G-CSF Biosimilars Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis G-CSF Biosimilars Products Offered
11.2.5 Novartis Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche G-CSF Biosimilars Products Offered
11.3.5 Roche Related Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Description and Business Overview
11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. G-CSF Biosimilars Products Offered
11.4.5 Merck & Co. Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi G-CSF Biosimilars Products Offered
11.5.5 Sanofi Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson G-CSF Biosimilars Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Gilead Science
11.7.1 Gilead Science Corporation Information
11.7.2 Gilead Science Description and Business Overview
11.7.3 Gilead Science Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Gilead Science G-CSF Biosimilars Products Offered
11.7.5 Gilead Science Related Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Description and Business Overview
11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.8.4 GlaxoSmithKline G-CSF Biosimilars Products Offered
11.8.5 GlaxoSmithKline Related Developments
11.9 AbbVie
11.9.1 AbbVie Corporation Information
11.9.2 AbbVie Description and Business Overview
11.9.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AbbVie G-CSF Biosimilars Products Offered
11.9.5 AbbVie Related Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Description and Business Overview
11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Amgen G-CSF Biosimilars Products Offered
11.10.5 Amgen Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer G-CSF Biosimilars Products Offered
11.1.5 Pfizer Related Developments
11.12 Bayer
11.12.1 Bayer Corporation Information
11.12.2 Bayer Description and Business Overview
11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bayer Products Offered
11.12.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 G-CSF Biosimilars Market Estimates and Projections by Region
12.1.1 Global G-CSF Biosimilars Sales Forecast by Regions 2021-2026
12.1.2 Global G-CSF Biosimilars Revenue Forecast by Regions 2021-2026
12.2 North America G-CSF Biosimilars Market Size Forecast (2021-2026)
12.2.1 North America: G-CSF Biosimilars Sales Forecast (2021-2026)
12.2.2 North America: G-CSF Biosimilars Revenue Forecast (2021-2026)
12.2.3 North America: G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.3 Europe G-CSF Biosimilars Market Size Forecast (2021-2026)
12.3.1 Europe: G-CSF Biosimilars Sales Forecast (2021-2026)
12.3.2 Europe: G-CSF Biosimilars Revenue Forecast (2021-2026)
12.3.3 Europe: G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific G-CSF Biosimilars Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: G-CSF Biosimilars Sales Forecast (2021-2026)
12.4.2 Asia Pacific: G-CSF Biosimilars Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: G-CSF Biosimilars Market Size Forecast by Region (2021-2026)
12.5 Latin America G-CSF Biosimilars Market Size Forecast (2021-2026)
12.5.1 Latin America: G-CSF Biosimilars Sales Forecast (2021-2026)
12.5.2 Latin America: G-CSF Biosimilars Revenue Forecast (2021-2026)
12.5.3 Latin America: G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa G-CSF Biosimilars Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: G-CSF Biosimilars Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: G-CSF Biosimilars Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: G-CSF Biosimilars Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key G-CSF Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 G-CSF Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. G-CSF Biosimilars Market Segments
Table 2. Ranking of Global Top G-CSF Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global G-CSF Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Human Growth Hormone
Table 5. Major Manufacturers of Erythropoietin
Table 6. Major Manufacturers of Monoclonal Antibodies
Table 7. Major Manufacturers of Insulin
Table 8. Major Manufacturers of Interferon
Table 9. Major Manufacturers of Granulocyte-Colony Stimulating Factor
Table 10. Global G-CSF Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global G-CSF Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global G-CSF Biosimilars Sales by Regions 2015-2020 (K Units)
Table 13. Global G-CSF Biosimilars Sales Market Share by Regions (2015-2020)
Table 14. Global G-CSF Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global G-CSF Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global G-CSF Biosimilars Sales Share by Manufacturers (2015-2020)
Table 17. Global G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global G-CSF Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in G-CSF Biosimilars as of 2019)
Table 19. G-CSF Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers G-CSF Biosimilars Price (2015-2020) (USD/Unit)
Table 22. G-CSF Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers G-CSF Biosimilars Product Type
Table 24. Date of International Manufacturers Enter into G-CSF Biosimilars Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 27. Global G-CSF Biosimilars Sales Share by Type (2015-2020)
Table 28. Global G-CSF Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 29. Global G-CSF Biosimilars Revenue Share by Type (2015-2020)
Table 30. G-CSF Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 32. Global G-CSF Biosimilars Sales Share by Application (2015-2020)
Table 33. North America G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 34. North America G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 35. North America G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 36. North America G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 37. North America G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 38. North America G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 39. North America G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 40. North America G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 41. Europe G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 42. Europe G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 43. Europe G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 45. Europe G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 46. Europe G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 47. Europe G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 48. Europe G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific G-CSF Biosimilars Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific G-CSF Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 57. Latin America G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 58. Latin America G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 61. Latin America G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 62. Latin America G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 63. Latin America G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 64. Latin America G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Major Businesses
Table 75. Pfizer G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Pfizer Product
Table 77. Pfizer Recent Development
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Major Businesses
Table 80. Novartis G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Novartis Product
Table 82. Novartis Recent Development
Table 83. Roche Corporation Information
Table 84. Roche Description and Major Businesses
Table 85. Roche G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Roche Product
Table 87. Roche Recent Development
Table 88. Merck & Co. Corporation Information
Table 89. Merck & Co. Description and Major Businesses
Table 90. Merck & Co. G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Merck & Co. Product
Table 92. Merck & Co. Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Major Businesses
Table 95. Sanofi G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Major Businesses
Table 100. Johnson & Johnson G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Recent Development
Table 103. Gilead Science Corporation Information
Table 104. Gilead Science Description and Major Businesses
Table 105. Gilead Science G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Gilead Science Product
Table 107. Gilead Science Recent Development
Table 108. GlaxoSmithKline Corporation Information
Table 109. GlaxoSmithKline Description and Major Businesses
Table 110. GlaxoSmithKline G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. GlaxoSmithKline Product
Table 112. GlaxoSmithKline Recent Development
Table 113. AbbVie Corporation Information
Table 114. AbbVie Description and Major Businesses
Table 115. AbbVie G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. AbbVie Product
Table 117. AbbVie Recent Development
Table 118. Amgen Corporation Information
Table 119. Amgen Description and Major Businesses
Table 120. Amgen G-CSF Biosimilars Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Amgen Product
Table 122. Amgen Recent Development
Table 123. AstraZeneca Corporation Information
Table 124. AstraZeneca Description and Major Businesses
Table 125. AstraZeneca G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. AstraZeneca Product
Table 127. AstraZeneca Recent Development
Table 128. Bayer Corporation Information
Table 129. Bayer Description and Major Businesses
Table 130. Bayer G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Bayer Product
Table 132. Bayer Recent Development
Table 133. Global G-CSF Biosimilars Sales Forecast by Regions (2021-2026) (K Units)
Table 134. Global G-CSF Biosimilars Sales Market Share Forecast by Regions (2021-2026)
Table 135. Global G-CSF Biosimilars Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 136. Global G-CSF Biosimilars Revenue Market Share Forecast by Regions (2021-2026)
Table 137. North America: G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 138. North America: G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Europe: G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 140. Europe: G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Asia Pacific: G-CSF Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 142. Asia Pacific: G-CSF Biosimilars Revenue Forecast by Region (2021-2026) (US$ Million)
Table 143. Latin America: G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 144. Latin America: G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Middle East and Africa: G-CSF Biosimilars Sales Forecast by Country (2021-2026) (K Units)
Table 146. Middle East and Africa: G-CSF Biosimilars Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key G-CSF Biosimilars Players
Table 151. G-CSF Biosimilars Customers List
Table 152. G-CSF Biosimilars Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. G-CSF Biosimilars Product Picture
Figure 2. Global G-CSF Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Human Growth Hormone Product Picture
Figure 4. Erythropoietin Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Insulin Product Picture
Figure 7. Interferon Product Picture
Figure 8. Granulocyte-Colony Stimulating Factor Product Picture
Figure 9. Global G-CSF Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 10. Blood Disorders
Figure 11. Oncology Diseases
Figure 12. Chronic And Autoimmune Diseases
Figure 13. Growth Hormone Deficiencies
Figure 14. G-CSF Biosimilars Report Years Considered
Figure 15. Global G-CSF Biosimilars Market Size 2015-2026 (US$ Million)
Figure 16. Global G-CSF Biosimilars Sales 2015-2026 (K Units)
Figure 17. Global G-CSF Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Figure 19. Global G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 20. Global G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Figure 21. Global G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 22. Global G-CSF Biosimilars Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by G-CSF Biosimilars Revenue in 2019
Figure 24. G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Figure 26. Global G-CSF Biosimilars Sales Market Share by Type in 2019
Figure 27. Global G-CSF Biosimilars Revenue Market Share by Type (2015-2020)
Figure 28. Global G-CSF Biosimilars Revenue Market Share by Type in 2019
Figure 29. Global G-CSF Biosimilars Market Share by Price Range (2015-2020)
Figure 30. Global G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Figure 31. Global G-CSF Biosimilars Sales Market Share by Application in 2019
Figure 32. Global G-CSF Biosimilars Revenue Market Share by Application (2015-2020)
Figure 33. Global G-CSF Biosimilars Revenue Market Share by Application in 2019
Figure 34. North America G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 37. North America G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 38. U.S. G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America G-CSF Biosimilars Market Share by Type in 2019
Figure 43. North America G-CSF Biosimilars Market Share by Application in 2019
Figure 44. Europe G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 47. Europe G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 48. Germany G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 51. France G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe G-CSF Biosimilars Market Share by Type in 2019
Figure 59. Europe G-CSF Biosimilars Market Share by Application in 2019
Figure 60. Asia Pacific G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 63. Asia Pacific G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 64. China G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 65. China G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 71. India G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific G-CSF Biosimilars Market Share by Type in 2019
Figure 87. Asia Pacific G-CSF Biosimilars Market Share by Application in 2019
Figure 88. Latin America G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 91. Latin America G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 92. Mexico G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America G-CSF Biosimilars Market Share by Type in 2019
Figure 99. Latin America G-CSF Biosimilars Market Share by Application in 2019
Figure 100. Middle East and Africa G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 103. Middle East and Africa G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 104. Turkey G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa G-CSF Biosimilars Market Share by Type in 2019
Figure 111. Middle East and Africa G-CSF Biosimilars Market Share by Application in 2019
Figure 112. North America G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa G-CSF Biosimilars Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa G-CSF Biosimilars Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年） A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of q…- G-CSF・G-CSFバイオシミラーの世界市場（～2026年） G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimu…
- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- HGHバイオシミラーの世界市場（～2026年） HGH Biosimilars is DNA recombinant human growth hormone, which has the same function as human growth hormone. It can promote bone, visceral and whole body growth, promote protein synthesis, affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection…
- 生物製剤・バイオシミラーの世界市場（～2026年） Market Analysis and Insights: Global Biologics & Biosimilars Market The global Biologics & Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biologics & Biosimilars Scope and Market Size Biologics & Biosimila…